Beta Bionics, Inc. recalls iLet Bionic Pancreas
- Published
- 6 May 2026
- Units affected
- 1,080
- Agency
- FDA
- Country
- United States
The hazard
Insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
iLet Bionic Pancreas, REF: BB1001
- Brand / company
- Beta Bionics, Inc.
- Codes / lots
- Software versions 1.4.3, and 1.4.2
- Distribution
- US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 6 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.